tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Atea Pharmaceuticals Inc

AVIR
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
4.810USD
+0.080+1.69%
์ข…๊ฐ€ย 07-27 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
384.93M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

AVIR ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Atea Pharmaceuticals Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Atea Pharmaceuticals Inc ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
May 12, 2026
EPS / ์˜ˆ์ƒ
-0.57/-0.59
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
--
--
EPS(YoY)
-1.94
2.76%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/07/27
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-42.56%-0.57
-44.64%-0.57
-44.15%-0.53
7.74%-0.44
46.54%-0.40
15.39%-0.40
7.15%-0.37
-42.32%-0.48
-76.87%-0.75
-13.54%-0.47
---0.40
---0.34
---0.43
---0.41
---0.98
----
----
----
----
----
์ˆ˜์ต
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
295.16%192.18M
--32.81M
--60.39M
์ˆœ์ด์ต
-32.59%-45.44M
-33.76%-44.87M
-34.98%-42.05M
8.29%-37.16M
45.75%-34.27M
14.35%-33.54M
6.01%-31.15M
-43.78%-40.52M
-78.11%-63.17M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-129.40%-34.43M
71.39%-8.07M
-2136.06%-31.34M
-237.00%-42.08M
467.06%117.13M
-59.99%-28.19M
115.40%1.54M
๋ถ€์ฑ„๋น„์œจ
----
----
----
----
----
----
----
--0.00%
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
์ˆ˜์ต
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
295.16%192.18M
--32.81M
--60.39M
์˜์—… ์ด์ต
-26.98%-48.01M
-55.14%-54.71M
-46.79%-45.45M
-16.92%-41.42M
-23.74%-37.81M
-24.40%-35.27M
-0.99%-30.97M
-20.89%-35.43M
6.33%-30.55M
-4.70%-28.35M
-15.60%-30.66M
-2.26%-29.31M
-13.09%-32.62M
-119.45%-27.08M
-516.52%-26.52M
-176.37%-28.66M
-159.15%-28.84M
363.90%139.22M
167.48%6.37M
906.88%37.53M
์ˆœ์ด์ต
-32.59%-45.44M
-33.76%-44.87M
-34.98%-42.05M
8.29%-37.16M
45.75%-34.27M
14.35%-33.54M
6.01%-31.15M
-43.78%-40.52M
-78.11%-63.17M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-129.40%-34.43M
71.39%-8.07M
-2136.06%-31.34M
-237.00%-42.08M
467.06%117.13M
-59.99%-28.19M
115.40%1.54M
์œ ๋™์ž์‚ฐ
-39.31%263.20M
-32.74%310.99M
-30.96%336.14M
-23.85%385.60M
-20.97%433.71M
-21.70%462.36M
-19.30%486.91M
-18.44%506.37M
-13.22%548.76M
-10.66%590.46M
-11.53%603.32M
-9.95%620.83M
-11.33%632.39M
-14.43%660.92M
-19.10%681.93M
-20.85%689.45M
-15.11%713.23M
-10.55%772.40M
677.53%842.95M
635.42%871.11M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
53.43%33.37M
113.86%39.78M
-19.91%20.18M
-24.42%20.12M
-47.36%21.75M
-42.54%18.60M
33.33%25.19M
64.73%26.62M
234.20%41.31M
75.21%32.38M
20.85%18.89M
-35.64%16.16M
-56.79%12.36M
-67.52%18.48M
-94.03%15.63M
-90.83%25.11M
-88.75%28.61M
-81.99%56.88M
2322.82%262.05M
3777.20%273.65M
์ด ์ž์‚ฐ
-39.30%267.08M
-32.16%315.22M
-30.14%342.96M
-23.27%391.61M
-20.44%439.96M
-21.90%464.67M
-19.26%490.96M
-18.47%510.38M
-13.34%553.03M
-10.76%594.97M
-11.43%608.08M
-9.84%626.03M
-11.02%638.13M
-13.74%666.71M
-18.60%686.58M
-20.33%694.34M
-14.69%717.19M
-10.51%772.89M
666.08%843.50M
627.83%871.54M
๋ถ€์ฑ„ ์ด๊ณ„
15.54%33.37M
54.20%39.78M
-16.19%27.18M
-19.83%27.19M
-40.65%28.88M
-35.13%25.80M
23.12%32.44M
43.22%33.91M
143.91%48.66M
52.19%39.78M
12.64%26.34M
-30.11%23.68M
-46.52%19.95M
-58.39%26.14M
-91.07%23.39M
-87.62%33.88M
-85.34%37.30M
-80.11%62.81M
2310.34%262.05M
3740.07%273.68M
์ž๋ณธ ์ด๊ณ„
-43.15%233.71M
-37.24%275.43M
-31.13%315.78M
-23.52%364.42M
-18.50%411.08M
-20.95%438.87M
-21.18%458.52M
-20.90%476.47M
-18.41%504.37M
-13.33%555.19M
-12.28%581.73M
-8.80%602.35M
-9.08%618.18M
-9.79%640.57M
14.06%663.19M
10.47%660.46M
15.97%679.88M
29.62%710.08M
485.94%581.45M
430.88%597.86M
์ˆœ์˜์—…์ด์ต
-51.79%-46.39M
7.15%-28.22M
-75.28%-40.38M
22.11%-32.87M
23.33%-30.56M
-39.22%-30.40M
-30.95%-23.04M
-161.80%-42.20M
-33.55%-39.87M
-1.34%-21.83M
17.19%-17.59M
15.98%-16.12M
49.41%-29.85M
71.43%-21.55M
-193.98%-21.24M
-10.59%-19.19M
-250.47%-59.01M
-123.68%-75.42M
338.40%22.60M
-122.47%-17.35M
์ˆœํˆฌ์ž
-65.26%29.74M
1482.55%46.59M
133.85%41.30M
-87.74%15.29M
50.71%85.61M
-112.13%-3.37M
-108.52%-122.01M
167.77%124.69M
132.03%56.80M
-17.07%27.77M
87.98%-58.51M
2578.18%46.56M
55736.36%24.48M
837300.00%33.49M
---486.98M
---1.88M
---44.00K
20.00%-4.00K
100.00%0.00
100.00%0.00
์ˆœ์žฌ๋ฌดํ™œ๋™
174.06%257.00K
--0.00
-9762.39%-11.30M
---14.09M
-331.33%-347.00K
--0.00
27.17%117.00K
--0.00
-9.09%150.00K
--0.00
-37.41%92.00K
--0.00
-26.01%165.00K
-100.00%0.00
-81.51%147.00K
-100.00%0.00
-52.65%223.00K
-99.97%142.00K
187.08%795.00K
-99.95%57.00K

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Atea Pharmaceuticals Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atea Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 310.99M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -32.74์ž…๋‹ˆ๋‹ค.

Atea Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atea Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Atea Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ 315.22M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -32.16์ž…๋‹ˆ๋‹ค.

Atea Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atea Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Atea Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” 39.78M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 54.20์ž…๋‹ˆ๋‹ค.

Atea Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atea Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Atea Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ 275.43M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -37.24์ž…๋‹ˆ๋‹ค.

Atea Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atea Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Atea Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -179.40M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -35.68์ž…๋‹ˆ๋‹ค.

Atea Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atea Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Atea Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” 188.79M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 236.50์ž…๋‹ˆ๋‹ค.

Atea Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atea Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Atea Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ -25.75M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -9742.32์ž…๋‹ˆ๋‹ค.

Atea Pharmaceuticals Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atea Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -1.94์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2.76์ž…๋‹ˆ๋‹ค.

Atea Pharmaceuticals Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atea Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -158.35M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 5.96์ž…๋‹ˆ๋‹ค.

Atea Pharmaceuticals Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atea Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -44.34์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -30.87์ž…๋‹ˆ๋‹ค.

Atea Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atea Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -40.61์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -27.77์ž…๋‹ˆ๋‹ค.

Atea Pharmaceuticals Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atea Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -179.40M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -35.68์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ